BridgeMD
New treatment option for Heart Failure
Official title TEXT4HF: A Randomized Controlled Trial of a Tailored Text Messaging Intervention to Improve Self-Care in Older Adult Patients With Heart Failure
ClinicalTrials.gov ID: NCT06473532
What this study is testing
- What it's testing
- The goal of this study is to determine whether an individually tailored text messaging intervention can improve self-care in older adult patients with heart failure. The main question it aims to answer are: Is a tailored text messaging intervention feasible and acceptable among older adult patients with heart failure?
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 and older
You may be able to join if
- ≥50 years of Age
- HF Stage C, NYHA Class I-IV and on a loop diuretic
- Own a Mobile phone with Text message plan
- Ability to speak and read English
- Suboptimal HF self-care. (SCHFI Score of 3 or less in at least 2 items of any subscale: Self-care maintenance, Symptom Perception, or Self-management)
You likely can't join if
- SAVR/TAVR or Ventricular Assist Device, or Cardiac Resynchronization Therapy (CRT) - implantation, and/or heart transplantation (HTx) scheduled...
- Coronary revascularization, and/or CRT-implantation within the last 30 days (EMR Review)
- Psychosis
- Hospice or End-of-life care
- Advanced Renal disease (i.e., estimated Glomerular Filtration Rate \<25 or Hemodialysis)
- Cognitive impairment (i.e., Dementia, Alzheimer's)
See the full eligibility criteria
- ≥50 years of Age
- HF Stage C, NYHA Class I-IV and on a loop diuretic
- Own a Mobile phone with Text message plan
- Ability to speak and read English
- Suboptimal HF self-care. (SCHFI Score of 3 or less in at least 2 items of any subscale: Self-care maintenance, Symptom Perception, or Self-management)
- SAVR/TAVR or Ventricular Assist Device, or Cardiac Resynchronization Therapy (CRT) - implantation, and/or heart transplantation (HTx) scheduled within the next 3 months
- Coronary revascularization, and/or CRT-implantation within the last 30 days (EMR Review)
- Psychosis
- Hospice or End-of-life care
- Advanced Renal disease (i.e., estimated Glomerular Filtration Rate \<25 or Hemodialysis)
- Cognitive impairment (i.e., Dementia, Alzheimer's)
- Unable to self-manage (take medication, bathe, use the toilet, etc.)
- Currently living in a nursing home
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.